Eli Lilly (LLY) Q1 Earnings Top, Sales Miss, 2024 View Raised

Eli Lilly and Company (LLY) reported first-quarter 2024 adjusted earnings per share (“EPS”) of $2.58, which beat the Zacks Consensus Estimate of $2.53 per share. Earnings rose 59% year over year.Revenues of $8.77 billion rose 26% year over year. Total revenues, however, missed the Zacks Consensus Estimate of $8.81 billion.Quarter in DetailIn the reported quarter, net realized prices rose 10%, while volumes rose 16%.Key growth products (select products launched prior to 2022 like Cyramza, Emgality, Jardiance ...